Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorvardur R Halfdanarson

Showing results (151-160 of 213) with videos related to

Pageof 22
Sort By:
Annals of Surgical Oncology|December 19, 2025
The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases: A Retrospective Single-Center AnalysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Mayo Clinic Proceedings|August 2, 2025
Impact of Tumor Burden and Cardiac Factors on Survival After Valve Surgery for Carcinoid Heart DiseaseTedy Sawma, Hartzell V Schaff, Gokce Belge Bilgin, et al.
Endocrine-Related Cancer|February 11, 2025
Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomaShruti Chandra, Thorvardur R Halfdanarson, Erin E Carlson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2023
Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line settingBahar Saberzadeh-Ardestani, Jeremy C Jones, Robert R McWilliams, et al.
Annals of Surgical Oncology|December 9, 2025
The Role of Primary Tumor Resection in Surgical Management of Asymptomatic Metastatic PNETs: A Retrospective Single-Center StudyVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Frontiers in Oncology|July 29, 2024
Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer <sup>177</sup>Lu-PSMA-617 therapyGokce Belge Bilgin, Cem Bilgin, Daniel S Childs, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 26, 2025
Cause of death after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: a single center retrospective analysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Journal of Gastrointestinal Oncology|January 18, 2021
Chemoradiotherapy for patients with locally advanced or unresectable extra-hepatic biliary cancerKrishan R Jethwa, Shilpa Sannapaneni, Trey C Mullikin, et al.
Clinical Genitourinary Cancer|April 8, 2023
Urinary Neuroendocrine Neoplasms Treated in the "Modern Era": A Multicenter Retrospective ReviewBryan Khuong Le, Patrick McGarrah, Alan Paciorek, et al.
Annals of Surgical Oncology|June 25, 2025
Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine NeoplasmsDavid G Su, Leanne M Brown, Varun V Bansal, et al.
Pageof 22

Showing results (151-160 of 213) with videos related to

Sort By:
Pageof 22
Annals of Surgical Oncology|December 19, 2025
The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases: A Retrospective Single-Center AnalysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Mayo Clinic Proceedings|August 2, 2025
Impact of Tumor Burden and Cardiac Factors on Survival After Valve Surgery for Carcinoid Heart DiseaseTedy Sawma, Hartzell V Schaff, Gokce Belge Bilgin, et al.
Endocrine-Related Cancer|February 11, 2025
Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomaShruti Chandra, Thorvardur R Halfdanarson, Erin E Carlson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2023
Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line settingBahar Saberzadeh-Ardestani, Jeremy C Jones, Robert R McWilliams, et al.
Annals of Surgical Oncology|December 9, 2025
The Role of Primary Tumor Resection in Surgical Management of Asymptomatic Metastatic PNETs: A Retrospective Single-Center StudyVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Frontiers in Oncology|July 29, 2024
Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer <sup>177</sup>Lu-PSMA-617 therapyGokce Belge Bilgin, Cem Bilgin, Daniel S Childs, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 26, 2025
Cause of death after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: a single center retrospective analysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Journal of Gastrointestinal Oncology|January 18, 2021
Chemoradiotherapy for patients with locally advanced or unresectable extra-hepatic biliary cancerKrishan R Jethwa, Shilpa Sannapaneni, Trey C Mullikin, et al.
Clinical Genitourinary Cancer|April 8, 2023
Urinary Neuroendocrine Neoplasms Treated in the "Modern Era": A Multicenter Retrospective ReviewBryan Khuong Le, Patrick McGarrah, Alan Paciorek, et al.
Annals of Surgical Oncology|June 25, 2025
Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine NeoplasmsDavid G Su, Leanne M Brown, Varun V Bansal, et al.
Pageof 22